cysteamine has been researched along with Cholera Infantum in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chrysselis, MC; Kourounakis, AP; Kourounakis, PN; Rekka, EA; Siskou, IC; Tsiakitzis, K | 1 |
| Thoene, JG | 1 |
| Deutsch, R; Dohil, R; Newbury, RO; Schneider, JA; Sellers, ZM | 1 |
| PETRANYI, G; ZSEBOEK, Z | 1 |
| Barshop, B; Deutsch, R; Dohil, R; Fidler, M; Newbury, R; Schneider, J; Sellers, Z | 1 |
| Hibi, T; Masaoka, T; Suzuki, H | 1 |
| Bendel-Stenzel, MR; Dohil, R; Kim, Y; Steinke, J | 1 |
| Bernardini, I; Gahl, WA; Hyman, PE; Ingelfinger, J; Mohan, P; Tangerman, A | 1 |
| Galanakis, D; Kourounakis, AP; Kourounakis, PN; Tsiakitzis, K | 1 |
1 review(s) available for cysteamine and Cholera Infantum
| Article | Year |
|---|---|
[Ghrelin - a novel appetite-stimulating hormone which also affects gastrointestinal functions].
Topics: Appetite; Cysteamine; Dyspepsia; Eating; Gastrointestinal Diseases; Ghrelin; Humans; Peptic Ulcer | 2006 |
8 other study(ies) available for cysteamine and Cholera Infantum
| Article | Year |
|---|---|
Design and study of some novel ibuprofen derivatives with potential nootropic and neuroprotective properties.
Topics: Animals; Antioxidants; Arthritis, Experimental; Biphenyl Compounds; Blood-Brain Barrier; Cholesterol; Cholinesterase Inhibitors; Cyclooxygenase 2 Inhibitors; Freund's Adjuvant; Gastrointestinal Diseases; Glutathione; Hyperlipidemias; Hypoxia-Ischemia, Brain; Ibuprofen; Lipid Peroxidation; Lipoxygenase Inhibitors; Mice; Microsomes, Liver; Neuroprotective Agents; Nootropic Agents; Oxidative Stress; Picrates; Rats; Spleen; Triglycerides | 2007 |
Myopathy and Less Frequent Complications of Cystinosis.
Topics: Cardiovascular Diseases; Cysteamine; Cystinosis; Gastrointestinal Diseases; Humans; Muscular Diseases | 2017 |
The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine.
Topics: Anti-Ulcer Agents; Child; Child, Preschool; Cysteamine; Cystinosis; Female; Gastric Acid; Gastrins; Gastrointestinal Diseases; Gastroscopy; Humans; Male; Omeprazole; Stomach | 2003 |
[ON THE PROTECTIVE EFFECT OF MERCAPTAMINE ON WATER-ELECTROLYTE BALANCE DISORDERS IN GASTROINTESTINAL RADIATION SYNDROME].
Topics: Animals; Cysteamine; Electrolytes; Gastrointestinal Diseases; Mercaptoethylamines; Pharmacology; Radiation Injuries; Radiation Injuries, Experimental; Rats; Research; Water-Electrolyte Balance | 1964 |
Esomeprazole therapy for gastric acid hypersecretion in children with cystinosis.
Topics: Child; Child, Preschool; Cysteamine; Cystinosis; Enzyme Inhibitors; Esomeprazole; Female; Gastric Acid; Gastrins; Gastrointestinal Diseases; Gastroscopy; Humans; Intestinal Mucosa; Male; Retrospective Studies; Severity of Illness Index | 2005 |
Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cysteamine; Cystinosis; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Hypothyroidism; Infant; Injections, Intravenous; Kidney Transplantation; Radiation-Protective Agents; Renal Insufficiency | 2008 |
Intravenous cysteamine therapy for nephropathic cystinosis.
Topics: Child, Preschool; Cysteamine; Cystine; Cystinosis; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Injections, Intravenous; Leukocytes; Male; Microscopy, Electron; Sulfides | 1995 |
Reduction of gastrointestinal toxicity of NSAIDs via molecular modifications leading to antioxidant anti-inflammatory drugs.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cysteamine; Drug Design; Female; Free Radical Scavengers; Gastrointestinal Diseases; Rats; Rats, Inbred F344 | 2000 |